Coloplast

Coloplast CLPBF Stock

$74.32   -1.432363%
Add to favorites
Market Cap
$16.75B
LOW - HIGH [24H]
$75.25 - $75.25
VOLUME [24H]
$100.00
P/E Ratio
35.05
Earnings per share
$2.12
ISIN
DK0060448595
Price   Prediction

Coloplast Price Chart

Sorry, that's all we've gotfor now...

Coloplast (CLPBF) stock price today is 74.32 USD on OTC Markets OTCPK (-1.43% on the day). Updated .

Coloplast CLPBF Financial and Trading Overview

Coloplast stock price 74.32 USD
Previous Close 75.4 USD
Open 75.25 USD
Bid 72.54 USD x 10000
Ask 76.71 USD x 10000
Day's Range 75.25 - 75.25 USD
52 Week Range 56.81 - 91 USD
Volume 100 USD
Avg. Volume 1.95K USD
Market Cap 16.75B USD
Beta (5Y Monthly) 0.567
PE Ratio (TTM) 35.056606
EPS (TTM) 2.12 USD
Forward Dividend & Yield 3.58 (4.82%)
Ex-Dividend Date May 18, 2026
1y Target Est N/A

CLPBF Valuation Measures

Enterprise Value 37.76B USD
Trailing P/E 35.056606
Forward P/E 16.929386
PEG Ratio (5 yr expected) 1.36
Price/Sales (ttm) 0.57874155
Price/Book (mrq) 7.798558
Enterprise Value/Revenue 1.305
Enterprise Value/EBITDA 4.486

Trading Information

Coloplast Stock Price History

Beta (5Y Monthly) 0.567
52-Week Change -16.58%
S&P500 52-Week Change 12.07%
52 Week High 91 USD
52 Week Low 56.81 USD
50-Day Moving Average 67.36 USD
200-Day Moving Average 66.4 USD

CLPBF Share Statistics

Avg. Volume (3 month) 1.95K USD
Avg. Daily Volume (10-Days) 7.82K USD
Shares Outstanding 207.37M
Float 144.7M
Short Ratio N/A
% Held by Insiders 29.79%
% Held by Institutions 29.84%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 23
Trailing Annual Dividend Yield 30.50%
5 Year Average Dividend Yield 276.00%
Payout Ratio 1.6861999
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2026
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End September 30, 2027

Profitability

Profit Margin 10.62%
Operating Margin (ttm) 25.73%
Gross Margin 66.50%
EBITDA Margin 29.08%

Management Effectiveness

Return on Assets (ttm) 9.83%
Return on Equity (ttm) 20.21%

Income Statement

Revenue (ttm) 28.94B USD
Revenue Per Share (ttm) 128.4 USD
Quarterly Revenue Growth (yoy) 7.19%
Gross Profit (ttm) 19.25B USD
EBITDA 8.42B USD
Net Income Avi to Common (ttm) 3.07B USD
Diluted EPS (ttm) 2.12
Quarterly Earnings Growth (yoy) 35.50%

Balance Sheet

Total Cash (mrq) 511M USD
Total Cash Per Share (mrq) 2.27 USD
Total Debt (mrq) 21.52B USD
Total Debt/Equity (mrq) 150.56 USD
Current Ratio (mrq) 0.739
Book Value Per Share (mrq) 9.529966

Cash Flow Statement

Operating Cash Flow (ttm) 8.01B USD
Levered Free Cash Flow (ttm) 6.65B USD

Profile of Coloplast

Country United States
State N/A
City Humlebæk
Address Holtedam 1-3
ZIP 3050
Phone 45 49 11 11 11
Website https://www.coloplast.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 17270

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through five segments: Chronic Care, Voice & Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Q&A For Coloplast Stock

What is a current CLPBF stock price?

Coloplast CLPBF stock price today per share is 74.32 USD.

How to purchase Coloplast stock?

You can buy CLPBF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Coloplast?

The stock symbol or ticker of Coloplast is CLPBF.

Which industry does the Coloplast company belong to?

The Coloplast industry is Medical Instruments & Supplies.

How many shares does Coloplast have in circulation?

The max supply of Coloplast shares is 225.37M.

What is Coloplast Price to Earnings Ratio (PE Ratio)?

Coloplast PE Ratio is 35.05660600 now.

What was Coloplast earnings per share over the trailing 12 months (TTM)?

Coloplast EPS is 2.12 USD over the trailing 12 months.

Which sector does the Coloplast company belong to?

The Coloplast sector is Healthcare.

$2.18T
Total marketcap
$71.81B
Total volume
BTC 58.08%   •   ETH 9.96%
Dominance
Select currency